drugset / Trial / NCT03412513
Mirabegron for Treatment of Overactive Bladder Symptoms in Patients With Parkinson's Disease
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to see the study drug, Mirabegron, is safe and effective in treating symptoms of Overactive Bladder in patients with Parkinson's disease.
Timeline
- Start
- 2017-07-17
- Primary completion
- 2018-07-16
- Completion
- 2018-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Mirabegron | Other / unclassified | 50 mg | Oral |